| Current Price | $3.82 | Mkt Cap | $179.7M |
|---|---|---|---|
| Open | $3.53 | P/E Ratio | -0.83 |
| Prev. Close | $3.56 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.52 - $3.83 | Volume | 895,376 |
| 52-Wk Range | $3.01 - $17.56 | Avg. Daily Vol. | 1,265,469 |
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma.
| Current Price | $3.82 | Mkt Cap | $179.7M |
|---|---|---|---|
| Open | $3.53 | P/E Ratio | -0.83 |
| Prev. Close | $3.56 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $3.52 - $3.83 | Volume | 895,376 |
| 52-Wk Range | $3.01 - $17.56 | Avg. Daily Vol. | 1,265,469 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about TSVT.
Find the members with the highest scoring picks in TSVT.
TMFacarchidi (< 20) Score: +45.54
The Score Leader is the player with the highest score across all their picks in TSVT.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TMFacarchidi | < 20 | 3/31/2022 |
|
3Y | $17.39 | -78.35% | -6.48% | +71.87 | 0 Comment | |
| TMFSaintCroix | 86.52 | 2/10/2022 |
|
5Y | $16.56 | -77.26% | -6.08% | -71.19 | 0 Comment | |
| cheev | 99.98 | 12/13/2021 |
|
5Y | $30.91 | -87.82% | -8.42% | -79.40 | 0 Comment | |
| JohnnyCaffeine | < 20 | 12/14/2021 |
|
5Y | $28.34 | -86.71% | -7.01% | -79.71 | 0 Comment | |
| 12x | < 20 | 7/18/2022 |
|
5Y | $14.27 | -73.62% | +10.27% | -83.88 | 0 Comment | |
| mcdbenbe | 21.83 | 11/14/2022 |
|
5Y | $16.49 | -77.17% | +7.97% | -85.13 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
